On August 5, 2025, Organogenesis Holdings Inc. amended its Credit Agreement to suspend a financial ratio test for the June 2025 quarter and will negotiate new financial covenants before September 30, 2025, while stating that they have enough cash to cover 12 months of expenses. The company also announced its fiscal Q2 results on August 7, 2025.